Navigation Links
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of BioAmber Inc. (BIOA)
Date:3/20/2017

NEW YORK, March 20, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the BioAmber Inc. ("BioAmber" or the "Company") (NYSE: BIOA). Such investors are advised to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/bioa.

The investigation concerns whether BioAmber and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On March 16, 2017 after-market hours, BioAmber revealed disappointing financial results for its 2016 fiscal year, missing its previously issued revenue forecast by $1.3 million. On the conference call, company's President Fabrice Orecchioni, attributed the unfortunate results to "pricing pressures" and "a disruption from a large customer that was expected to purchase 2.8 million of succinic acid in Q4 2016, but due to a technical problem in its manufacturing facility postponed the order to 2017." Following this news, BioAmber stock dropped during intraday trading on March 17, 2017.

If you are aware of any facts relating to this investigation, or purchased BioAmber shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/bioa.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-bioamber-inc-bioa-300425843.html


'/>"/>
SOURCE Bronstein, Gewirtz & Grossman, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Origin Agritech Announces Date for Special Meeting of Shareholders
2. Spherix Updates Shareholders
3. BD Announces Webcast of Annual Meeting of Shareholders
4. SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017
5. Biorem Reports Sale of Securities by Major Shareholders
6. Biostage CEO Provides Mid-Year Update to Shareholders
7. NantKwest Shareholder (NK) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of NantKwest, Inc.; Encourages Investors to Contact the Firm
8. Spherix Releases Update Letter to Shareholders
9. Spherix Moves to Maintain NASDAQ Compliance as Shareholders Approve Reverse Split
10. Asterias Biotherapeutics Announces Intention to Distribute 3.15 Million Warrants to Purchase Common Shares of Asterias to Asterias Shareholders
11. Oxis Chairman And CEO Tells Shareholders Biotech Company Making Substantial Progress With Lead Cancer Drug, Drawing Closer To NASDAQ Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... ... spoke at a Marketing Roundtable on March 22 in Philadelphia. The event was ... , The Marketing Roundtable featured breakout groups and interaction with ...
(Date:3/28/2017)... WASHINGTON , March 28, 2017  (AACR17, ... single-cell sequencing during the American Association for Cancer Research ... Center in Washington, D.C. , April ... gene expression of thousands of cells at the individual ... Experts on-hand at AACR to discuss expanded ...
(Date:3/28/2017)... , March 28, 2017 Dr. ... life sciences corporation Anpac Bio-Medical Science Company ... new, international record, processing and reporting over 40,000 ... Differentiation Analysis" (CDA) liquid biopsy tests. ... Prize Laureate Summit publications, Anpac Bio,s CDA medical ...
(Date:3/28/2017)... Focus is on the ... to the scientifically intensive operations of companies in ... and industrial. In today,s pre-market research, Stock-Callers.com dedicates attention ... PTLA), OvaScience Inc. (NASDAQ: OVAS), Ocera Therapeutics Inc. ... OCUL ). Learn more about these stocks ...
Breaking Biology Technology:
(Date:3/9/2017)... , March 9, 2017 4Dx has publicly ... Lung Imaging Workshop at the University of Pennsylvania. Founder ... to deliver the latest data to world leaders in ... brings together leaders at the forefront of the industry ... imaging. "The quality of the imaging ...
(Date:3/7/2017)... , March 7, 2017   HireVue , ... top global companies identify the best talent, faster, today ... Chief Sales Officer (CSO) and Diana Kucer ... round out a seasoned executive team poised to drive continued ... building on a year of record bookings in 2017. ...
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
Breaking Biology News(10 mins):